Literature DB >> 269401

Vasoactive intestinal polypeptide in brain: localization in and release from isolated nerve terminals.

A Giachetti, S I Said, R C Reynolds, F C Koniges.   

Abstract

The vasoactive intestinal polypeptide was present in synaptosomal (nerve ending) preparations from cerebral cortex, hypothalamus, and striatum of rat brain in higher concentrations than in these tissues as a whole. The total content and relative specific activity of the peptide increased with progressive purification of the synaptosomal fractions and generally followed the distribution of known synaptosomal constituents--dopamine, norepinephrine, and lactate dehydrogenase (L-lactate:NAD+ oxidoreductase, EC 1.1.1.27). The peptide was also released from synaptosomal pellets with increased K+ concentration, and this release was Ca2+-dependent. The findings suggest a role for vasoactive intestinal polypeptide as a transmitter or modulator of synaptic function.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 269401      PMCID: PMC431590          DOI: 10.1073/pnas.74.8.3424

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  Release of substance P from isolated nerve endings.

Authors:  C Schenker; E A Mroz; S E Leeman
Journal:  Nature       Date:  1976 Dec 23-30       Impact factor: 49.962

2.  LACTATE DEHYDROGENASE AS A CYTOPLASMIC MARKER IN BRAIN.

Authors:  M K JOHNSON; V P WHITTAKER
Journal:  Biochem J       Date:  1963-09       Impact factor: 3.857

3.  A SENSITIVE METHOD FOR SPECTROPHOTOFLUOROMETRIC ASSAY OF CATECHOLAMINES.

Authors:  C C CHANG
Journal:  Int J Neuropharmacol       Date:  1964-12

4.  The isolation and characterization of acetylcholine-containing particles from brain.

Authors:  V P WHITTAKER
Journal:  Biochem J       Date:  1959-08       Impact factor: 3.857

5.  Biochemistry of dystrophic muscle. Mitochondrial succinate-tetrazolium reductase and adenosine triphosphatase.

Authors:  R J PENNINGTON
Journal:  Biochem J       Date:  1961-09       Impact factor: 3.857

6.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

7.  Vasoactive intestinal polypeptide in brain synaptosomes.

Authors:  A Giachetti; R N Rosenberg; S I Said
Journal:  Lancet       Date:  1976-10-02       Impact factor: 79.321

8.  Immunochemical evidence of cholecystokinin-like peptides in brain.

Authors:  G J Dockray
Journal:  Nature       Date:  1976-12-09       Impact factor: 49.962

Review 9.  Substance P.

Authors:  S E Leeman; E A Mroz
Journal:  Life Sci       Date:  1974-12-15       Impact factor: 5.037

10.  Release of luteinizing hormone releasing hormone and thyrotropin releasing hormone from a synaptosome-enriched fraction of hypothalamic homogenates.

Authors:  J Warberg; R L Eskay; A Barnea; R C Reynolds; J C Porter
Journal:  Endocrinology       Date:  1977-03       Impact factor: 4.736

View more
  28 in total

1.  Biosynthesis of an endogenous cannabinoid precursor in neurons and its control by calcium and cAMP.

Authors:  H Cadas; S Gaillet; M Beltramo; L Venance; D Piomelli
Journal:  J Neurosci       Date:  1996-06-15       Impact factor: 6.167

2.  Vasoactive intestinal polypeptide: specific binding to rat brain membranes.

Authors:  D P Taylor; C B Pert
Journal:  Proc Natl Acad Sci U S A       Date:  1979-02       Impact factor: 11.205

3.  Vasoactive intestinal peptide in the human pituitary gland and adenomas. An immunocytochemical study.

Authors:  D W Hsu; P N Riskind; E T Hedley-Whyte
Journal:  Am J Pathol       Date:  1989-08       Impact factor: 4.307

4.  Inhibition by vasoactive intestinal polypeptide (VIP) of angiogenesis induced by murine Colon 26-L5 carcinoma cells metastasized in liver.

Authors:  M Ogasawara; J Murata; Y Kamitani; K Hayashi; I Saiki
Journal:  Clin Exp Metastasis       Date:  1999-06       Impact factor: 5.150

5.  Immunocytochemistry of four mixed pituitary adenomas and intrasellar gangliocytomas associated with different clinical syndromes: acromegaly, amenorrhea-galactorrhea, Cushing's disease and isolated tumoral syndrome.

Authors:  J Y Li; O Racadot; M Kujas; M Kouadri; F Peillon; J Racadot
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

Review 6.  Vasoactive intestinal peptide.

Authors:  S I Said
Journal:  J Endocrinol Invest       Date:  1986-04       Impact factor: 4.256

7.  Localization of cholecystokinin-like immunoreactivity in isolated nerve terminals.

Authors:  M Pinget; E Straus; R S Yalow
Journal:  Proc Natl Acad Sci U S A       Date:  1978-12       Impact factor: 11.205

8.  Vasoactive intestinal polypeptide induces glycogenolysis in mouse cortical slices: a possible regulatory mechanism for the local control of energy metabolism.

Authors:  P J Magistretti; J H Morrison; W J Shoemaker; V Sapin; F E Bloom
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

9.  Vasoactive intestinal peptide (VIP).

Authors:  M G Bryant
Journal:  J Clin Pathol Suppl (Assoc Clin Pathol)       Date:  1978

10.  Vasoactive intestinal polypeptide stimulates the secretion of catecholamines from the rat adrenal gland.

Authors:  R K Malhotra; A R Wakade
Journal:  J Physiol       Date:  1987-07       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.